You are here: Industry Insights > CDMO

News List

Introducing ViroCell Biologics contractpharma
April 29, 2021
ViroCell Biologics, founded in the UK by a prolific academic viral vector manufacturing team, has officially launched. Viral vectors are the primary delivery method for innovative vaccines such as the Oxford/Astra Zeneca COVID vaccine, as well as ...
Biologics CDMO market to double in value by 2026, suggests report europeanpharmaceuticalreview
April 16, 2021
Research suggests the increasing R&D investment in and adoption of biologics will drive growth in the global biologics contract development and manufacturing organisation (CDMO) market.
Metrics Names Stephanie Emory Associate Director of Pharma Development contractpharma
April 16, 2021
Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, has appointed Stephanie Emory, PhD as associate director of pharmaceutical development.
Recro, Ensysce Expand Development and Manufacturing Partnership contractpharma
April 16, 2021
Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, has signed additional agreements with an existing ...
Ascendia Pharmaceuticals Poised for Expansion contractpharma
April 12, 2021
CDMO secures growth equity investment from Signet Healthcare Partners.
Recro Pharma Expands Business Development Team contractpharma
April 06, 2021
Recro Pharma Inc. has strengthened the company’s business development team to support its strategic objective of expanding and diversifying its customer base.
GRAM Attains EU GMP Certification for Commercial Aseptic Fill/Finish contractpharma
March 31, 2021
Grand River Aseptic Manufacturing (GRAM), an injectable CDMO, was recently audited by the Dutch Health and Youth Care Inspectorate (IGJ) and issued EU Good Manufacturing Practices (EU GMP) certificate.
KD Pharma Acquires Rohner AG Manufacturing Assets contractpharma
March 30, 2021
The KD Pharma Group has acquired the manufacturing assets of the former Rohner AG. The assets give KD Pharma access to new complementary technologies that will allow the company to further expand its pharmaceutical CDMO business.
Chime Biologics Expands CDMO Capabilities contractpharma
March 30, 2021
Chime Biologics, a China-based CDMO, has secured a total commitment of $190 million investment from institutional investors.
mAbxience Expands Biosimilar and CDMO Manufacturing Capacity contractpharma
March 26, 2021
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, said that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an ABEC 4,000L Custom Single Run (CSR) Bioreactor.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page